ClinicalTrials.gg
CompletedNCT07246538Updated Nov 5, 2026Results posted

Positive Airway Pressure (PAP) System Evaluation in Volunteers

An interventional study of CPAP in Obstruction Airway, sponsored by University of Utah. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by University of Utah · Not applicable, Interventional, and Device feasibility

How we know

Updated Nov 5, 2026Now CompletedResults posted+8 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 40 studies in Airway Obstruction with a site in United States — 8 open to participants now, 9 under way, none of them phase 3. Airway Obstruction · United States.

Enrollment
24th of 29
13 · median 41
Started
2026
with 1 other
No phase
23 of 40
4 open now
Registered
39th of 40
by date
Lead sponsor
2 of 40
University of Utah

Among the 40 studies in Airway Obstruction with a site in United States, this one is the 24th largest by enrollment of the 29 interventional ones that give a count, is one of 2 that started in 2026, is one of 23 with no phase, and was the 39th registered.

Airway Obstruction

148 studies on the registry are indexed under Airway Obstruction; 26 are open to participants now.

Browse Airway Obstruction studies →

Open to participants now

8 of the 40 studies in Airway Obstruction with a site in United States are open now. Recruiting first, the newest first:

3 more — sign in →

All 8 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 20 Airway Obstruction studies recruiting now, 13 (65%) set no upper age limit and 5 (25%) stop at 75 or younger; 3 take children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 40 studies in Airway Obstruction with a site in United States, or all of them as a file.
02

Study summary

This study will test the control and measurements of a new system for airway support in healthy volunteers. The goals of the study are to evaluate how accurately the system can stabilize airway pressure to a desired level, evaluate the accuracy of the system's reported volume of each breath (tidal volume), evaluate the accuracy of the system's reported respiratory rate, evaluate the accuracy of exhaled carbon dioxide monitoring with a standard carbon dioxide monitor when the novel PAP system is used, and evaluate general comfort of the volunteers while using the system.

Read the detailed description

Sedation procedures involve administering drugs to patients that reduce awareness and pain without complete loss of consciousness. A common side effect of these drugs is partial or complete obstruction of the airway by the airway tissue, inhibiting the flow of oxygen to the lungs. Research has shown that this risk can be effectively reduced by administering PAP therapy during sedation, which involves directing air flow into a tight-fitting mask over the patient's nostrils and/or mouth. However, non-invasive ventilators used for administering PAP therapy are expensive and large, and often not available in areas of the hospital where sedation procedures take place.

The investigators have developed a small and low-cost novel PAP system for use in sedation procedures that controls airway pressure to desired levels (a feature that is generally only available in larger and higher-cost devices), provides estimates for tidal volumes (generally only available with a non-invasive ventilator), provides respiratory rate estimates, and allows for more accurate monitoring of exhaled carbon dioxide with a standard carbon dioxide monitor using a novel approach that to the investigator's knowledge has not been published. The goal of investigator's study is to demonstrate the accuracy of these features in human subjects. The system is much smaller and less expensive than a non-invasive ventilator, provides enhanced respiratory monitoring, and has the potential to be a practical alternative that would make PAP therapy during sedation much more feasible.

The investigator's evaluation will primarily include evaluating the investigator's system's performance against an FDA cleared commercial respiratory monitor to verify accuracy. The investigators anticipate that the investigator's system will automatically adjust oxygen flow to maintain a desired airway pressure even in the presence of variables such as mask leak and patient inhalation flow. The investigators also anticipate that the investigator's system will provide tidal volume estimates within 15% of the respiratory monitor reference measurement, as well as respiratory rate estimates that closely match the respiratory monitor. The investigator's system employs a method that detects when the patient exhales and removes mask pressure during exhalation, and the investigators anticipate that this will result in improved comfort for the patient, as well as improved carbon dioxide monitoring accuracy, since removing flow during exhalation reduces dilution of the expired gas sample that is used for measuring exhaled carbon dioxide levels.

03

Conditions studied

  • Obstruction Airway

Browse trials for

Keywords

  • Device feasibility
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy volunteers

Exclusion criteria

Exclusion Criteria:

  • Have any respiratory or cardiovascular conditions
  • i.e., cold, allergies, congestion, pneumonia, lung cancer, , acute respiratory distress syndrome, etc.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • Experimental
    CPAP

    Enrolled healthy volunteers to examine airway pressure support through the investigational device.

    Device: CPAP

Interventions

  • DeviceCPAP

    Airway pressure support through the investigational device

06

What researchers measure

Primary outcomes

  1. Tidal Volume Accuracy

    The mean and standard deviation of the percent difference in tidal volume measurement between our PAP system and the respiratory monitor

    Time frame: During the intervention, up to 20 minutes

Secondary outcomes

  1. Respiratory Rate

    The average respiratory rate reported by the respiratory monitor and rate reported by the PAP system for each volunteer will be compared. The average difference for each volunteer will be calculated, and a 95% confidence interval will be constructed, with the ideal mean difference being zero with low variance.

    Time frame: During the intervention, up to 20 minutes

  2. EtCO2

    End-tidal carbon dioxide measurements at 10 cmH2O of mask pressure will be compared between when the system turned off flow during exhalation and when delivering flow throughout the entire breath. We anticipate that end-tidal CO2 levels will read lower when flow is delivered continuously during exhalation because of dilution of the expired gas, and this will be demonstrated by calculating the average difference in end-tidal CO2 between these two approaches.

    Time frame: During the intervention, up to 20 minutes

  3. Mask Pressure Control Accuracy

    The measured pressure in the mask compared to the set pressure in the 50 milliseconds immediately preceding inhalation will be assessed for evaluating pressure control. Average error will be calculated and a 95% confidence interval will be constructed. We anticipate the error to be less than 1 cmH2O.

    Time frame: During the intervention, up to 20 minutes

07

Results

Posted Nov 5, 2026

Participant flow

Participant flow — Overall Study
MilestoneIntervention: CPAP
Started13
Completed13
Not completed0

Outcome measures

PrimaryTidal Volume Accuracy

The mean and standard deviation of the percent difference in tidal volume measurement between our PAP system and the respiratory monitor

Time frame:
During the intervention, up to 20 minutes
Reported as:
Mean · Percent difference
Tidal Volume Accuracy
Percent differenceCPAP
Tidal Volume Accuracy-1.94 ± 5.44
SecondaryRespiratory Rate

The average respiratory rate reported by the respiratory monitor and rate reported by the PAP system for each volunteer will be compared. The average difference for each volunteer will be calculated, and a 95% confidence interval will be constructed, with the ideal mean difference being zero with low variance.

Time frame:
During the intervention, up to 20 minutes
Reported as:
Mean · difference in breaths/min
Respiratory Rate
difference in breaths/minCPAP
Respiratory Rate0.2 (0.09 to 0.31)
SecondaryEtCO2

End-tidal carbon dioxide measurements at 10 cmH2O of mask pressure will be compared between when the system turned off flow during exhalation and when delivering flow throughout the entire breath. We anticipate that end-tidal CO2 levels will read lower when flow is delivered continuously during exhalation because of dilution of the expired gas, and this will be demonstrated by calculating the average difference in end-tidal CO2 between these two approaches.

Time frame:
During the intervention, up to 20 minutes
Reported as:
Number · difference in mmHg
EtCO2
difference in mmHgCPAP
EtCO29.2
SecondaryMask Pressure Control Accuracy

The measured pressure in the mask compared to the set pressure in the 50 milliseconds immediately preceding inhalation will be assessed for evaluating pressure control. Average error will be calculated and a 95% confidence interval will be constructed. We anticipate the error to be less than 1 cmH2O.

Time frame:
During the intervention, up to 20 minutes
Reported as:
Mean · error in cmH2O
Mask Pressure Control Accuracy
error in cmH2OCPAP
Mask Pressure Control Accuracy0.268 (0.039 to 0.497)

Adverse events

Collected over From enrollment to the end of their participation, up to 30 minutes. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
CPAP0/13 (0%)0/13 (0%)0/13 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)CPAP
Mean38.9 (24 to 73)
Sex: Female, Male
Sex: Female, Male(Participants)CPAP
Female6
Male7
Race (NIH/OMB)
Race (NIH/OMB)(Participants)CPAP
American Indian or Alaska Native1
Asian4
Native Hawaiian or Other Pacific Islander1
Black or African American0
White6
More than one race1
Unknown or Not Reported0
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)CPAP
Hispanic or Latino2
Not Hispanic or Latino10
Unknown or Not Reported1
08

Study locations

1 site
  • University of Utah Pain Management Center
    Salt Lake City, Utah 84108, United States
09

References and documents

Publications

  • Burk KM, Sakata DJ, Kuck K, Orr JA. Comparing Nasal End-Tidal Carbon Dioxide Measurement Variation and Agreement While Delivering Pulsed and Continuous Flow Oxygen in Volunteers and Patients. Anesth Analg. 2020 Mar;130(3):715-724. doi: 10.1213/ANE.0000000000004004. PubMed 30633057 ↗
  • Fogarty M, Orr JA, Sakata D, Brewer L, Johnson K, Fang JC, Kuck K. A comparison of ventilation with a non-invasive ventilator versus standard O2 with a nasal cannula for colonoscopy with moderate sedation using propofol. J Clin Monit Comput. 2020 Dec;34(6):1215-1221. doi: 10.1007/s10877-019-00426-5. Epub 2019 Nov 23. PubMed 31760586 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2026 to primary completion in Mar 2026, 0 months.

Results were first posted in Nov 2026, 8 months after primary completion.

Of 36 non-industry interventional studies with no phase under Airway Obstruction, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 37. This study's 0 months is below that.

Counting every sponsor, half of 44 studies reached it within 16 months; a quarter within 3 and three quarters within 37.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: primary completion Jun 2026 → Mar 2026 and completion Jun 2026 → Mar 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 17, 2025
First posted
Nov 24, 2025
StartActual
Feb 10, 2026
Primary completionActual
Mar 4, 2026was Jun 2026
CompletionActual
Mar 4, 2026was Jun 2026
Results first posted
Nov 5, 2026
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Nov 5, 2026
Results
Results posted
posted Nov 5, 2026
Sites
1 site added — first site in United States
Show site
  • University of Utah Pain Management Center · Salt Lake City, United States
Nov 5, 2026
Start date
Feb 1, 2026→Feb 10, 2026 (actual)
Nov 5, 2026
Primary completion
Jun 30, 2026→Mar 4, 2026 (actual)
Nov 5, 2026
Study completion
Jun 30, 2026→Mar 4, 2026 (actual)
Nov 5, 2026
Enrollment
25 (estimated)→13 (actual)
Nov 5, 2026
Primary outcomes
1 time frame changed
What changed in the outcomes
  • Time frameTidal Volume AccuracyDuring the intervention → During the intervention, up to 20 minutes
Nov 5, 2026
Secondary outcomes
3 time frame changed, 1 description edited
What changed in the outcomes
  • Time frameRespiratory RateDuring the intervention → During the intervention, up to 20 minutes
  • Time frameEtCO2During the intervention → During the intervention, up to 20 minutes
  • Time frameMask Pressure Control AccuracyDuring the intervention → During the intervention, up to 20 minutes
  • DescriptionMask Pressure Control Accuracy: how it is measured was reworded
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Not yet recruiting→Completed
    Results posted
    1 site added — first site in United States
    Show site
    • University of Utah Pain Management Center · Salt Lake City, United States
    Start date Feb 1, 2026→Feb 10, 2026 (now actual)
    Primary completion Jun 30, 2026→Mar 4, 2026 (now actual)
    Study completion Jun 30, 2026→Mar 4, 2026 (now actual)
    Enrollment 25 (estimated)→13 (actual)
    Primary outcomes 1 time frame changed
    What changed in the outcomes
    • Time frameTidal Volume AccuracyDuring the intervention → During the intervention, up to 20 minutes
    Secondary outcomes 3 time frame changed, 1 description edited
    What changed in the outcomes
    • Time frameRespiratory RateDuring the intervention → During the intervention, up to 20 minutes
    • Time frameEtCO2During the intervention → During the intervention, up to 20 minutes
    • Time frameMask Pressure Control AccuracyDuring the intervention → During the intervention, up to 20 minutes
    • DescriptionMask Pressure Control Accuracy: how it is measured was reworded
    + 5 other changes: registry notes, index terms, verification date, arm descriptions and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07246538
Lead sponsor
University of Utah
Collaborators
Dynasthetics LLC
Responsible party
Sponsor
First posted
Nov 24, 2025
Start date
Feb 10, 2026
Primary completion
Mar 4, 2026
Completion
Mar 4, 2026
Results posted
Nov 5, 2026
Last update
Nov 5, 2026

Study contacts

Kai Kuck, PhD
principal investigator · University of Utah

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion